mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.5 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.5 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.5 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |